The MultiFlow® assay is a mode of action (MOA) assay in TK6 cells to evaluate potential genotoxic response to a test article or its metabolites. By assessing nuclear translocation and binding of p53, the assay discriminates genotoxicants from non-genotoxicants. Furthermore, double strand DNA breaks and mitotic checkpoint delays (G2/M block) results in persistent γH2AX foci and phosphorylation of H3, respectively (further discriminating clastogenicity from aneugenicity).

European Genetic Toxicology Workshop

Image of DNA strands.

Learn how to successfully execute genetic toxicology testing, satisfying regulatory criteria and smoothing your path to market in 's-Hertogenbosch, The Netherlands.

Register Today!

MultiFlow® Assay Highlights

  • This assay can be used to screen libraries of compounds for potential genotoxic effects (using as little as 5 mg or 200 µL of a 100 mM solution), or to follow up positive mammalian cell assay test results (e.g., micronucleus) when evidence for a non-DNA reactive (e.g., Ames negative) MOA is needed.
  • Up to four compounds can be analyzed concurrently in a series of 20 concentrations, with data acquired by flow cytometry 4- and 24-hours after treatment. Polyploidy, γH2AX shifts, population doubling, H3P+ mitotic cells, and p53 shifts are evaluated in nuclei after cellular lysis.
  • Using three different machine learning algorithms, the probability of genotoxicity, occurring via a clastogenic and/or aneugenic MOA is determined, based upon learning models generated from 24 chemicals spanning multiple MOA and molecular initiating events. For complex results, inter-laboratory cut-off values may be used for each endpoint to assess biological relevance.